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ABSTRACT 
The potential of aqueous extract of the leaves of Acalypha wilkesiana, to protect against car-
bon tetrachloride induced liver damage was investigated in Wistar albino rats. The carbon tet-
rachloride was prepared 1:5 (v:v) in olive oil, and administered subcutaneously at 1 mL/kg 
body weight. The extract was administered to both normal and carbon tetrachloride treated 
rats at 100, 200 and 300 mg/kg. On fractionation and gas chromatographic analysis of the 
crude aqueous extract, thirty nine known alkaloids were detected, consisting mainly of 
akuamidine (69.027 %), voacangine (26.226 %), echitamine (1.974 %), echitamidine 
(0.599 %), lupanine (0.521 %) and augustamine (0.278 %). Compared to test control, the 
treatment dose dependently produced significantly lower (P<0.05) alkaline phosphatase, as-
partate and alanine transaminase activities. Histopathological studies on the liver sections 
showed that pre-treatment with the extract protected against carbon tetrachloride induced fatty 
degeneration of hepatocytes, thus, confirming the results of the biochemical studies. The 
above results imply that treatment with the plant extract protects the liver against carbon tet-
rachloride induced hepatotoxicity, therefore, justifying the use of Acalypha wilkesiana in Af-
rican traditional health care for the management of liver problems. 
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INTRODUCTION 
Acalypha wilkesiana, a member of the 
spurge family (Euphorbiaceae), belongs to 
the genus Acalypha comprising about 570 
species (Riley, 1963, as cited in Ogundaini, 
2005). A large proportion of members of 
this genus are weeds while the others are 
ornamental plants. Acalypha wilkesiana is 
commonly called copperleaf, Joseph’s coat, 
fire dragon, beef steak plant and match-me-
if-you-can (Christman, 2004). Although 
native to Fiji and nearby islands in the 
South Pacific, it has spread to most parts of 
the world, especially the tropics of Africa, 
America and Asia. It is a popular outdoor 
plant that provides colour throughout the 
year, although it is also grown indoors as a 
container plant. Many cultivars are avail-
able with different leaf forms and colours: 
A. wilkesiana ‘Godseffiana’ has narrow, 
drooping, green leaves with creamy-white 
margins; 'Marginata' has coppery-green 
leaves with pink or crimson margins; 'Mac-
rophylla' has  larger leaves, variegated with 
bronze, cream, yellow and red; while 
'Musaica'  has green leaves that are mottled 
with orange and red (Gilman, 1999; 
Christman, 2004). In Southern Nigeria, the 
expressed juice or boiled decoction of the 
leaves of A. wilkesiana cv. Godseffiana is 
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used in traditional health care practice, for 
the management of gastrointestinal disor-
ders, fungal skin infections, hypertension 
and diabetes mellitus. The leaf-poultice is 
used in the treatment of headache, swell-
ings, colds and malaria (Akinyemi et al., 
2005). The seeds of A. wilkesiana are used 
in compounding a complex plant mixture 
used by traditional healers in South-West 
Nigeria to treat breast tumours and inflam-
mation (Bussing et al., 1999; Taraphdar et 
al., 2001). The antimicrobial (Akinyemi et 
al., 2005; Ogundaini, 2005; Oladunmoye, 
2006), hypolipidaemic (Ikewuchi, 2010; 
Ikewuchi and Ikewuchi, 2010), diuretic 
(Ikewuchi et al., 2009a), hypoglycaemic 
(Ikewuchi et al., 2009a, 2011a) and anti-
hypertensive (Ikewuchi et al., 2009b, 
2011b) properties of the leaves have been 
reported. 
Earlier analysis of the leaves of Acaly-
pha wilkesiana revealed the presence of 
sesquiterpenes, monoterpenes, triterpe-
noids, polyphenols, gallic acid, corilagin, 
geraniin, quercetin 3-O-rutinoside, 
kaempferol 3-O-rutinoside, saponins, tan-
nins, anthroquinone and glycosides (Ak-
inde, 1986; Adesina et al., 2000; Oladun-
moye, 2006). They were also found to be 
were rich in some potent hepatoprotective 
agents like vitamin C (Ikewuchi and Ike-
wuchi, 2009), flavonoids and tannic acid 
(Ikewuchi et al., 2010, 2011a). Therefore, 
in this study, the ability of an aqueous ex-
tract of the leaves of A. wilkesiana ‘Godsef-
fiana’ Muell Arg, to protect against carbon 
tetrachloride induced liver damage was in-
vestigated in Wistar albino rats. 
 
MATERIALS AND METHODS 
Collection of plant samples and prepara-
tion of plant extract  
Samples of the fresh Acalypha wilkesi-
ana plants (Figure 1) were collected from 
within the Choba and Abuja Campuses of 
the University of Port Harcourt, Nigeria. 
After due identification at the University of 
Port Harcourt Herbarium, Port Harcourt, 
they were cleaned, before removing their 
leaves, which were then oven dried at 55 °C 
and ground into powder. The resultant 
powder was soaked in hot distilled water 
for 12 h, after which the resultant mixture 
was filtered and the filtrate (hereinafter re-
ferred to as the aqueous extract) was stored 
in the refrigerator for subsequent use. A 
known volume of this extract was evapo-
rated to dryness, and the weight of the resi-
due obtained, was used to determine the 
concentration of the filtrate, which was in 
turn used to determine the dose of admini-
stration of the extract. The resultant crude 
aqueous residue was subjected to phyto-
chemical analysis. 
 
Figure 1: Acalypha wilkesiana Muell Arg 
Determination of the phytochemical 
content of the crude aqueous leaf ex-
tract 
Calibration, identification and quantifica-
tion 
Standard solutions were prepared in 
methanol. The linearity of the dependence 
of response on concentration was verified 
by regression analysis. Identification was 
based on comparison of retention times and 
spectral data with standards. Quantification 
was performed by establishing calibration 
curves for each compound determined, us-
ing the standards.  
 
Determination of alkaloid composition 
The extraction of the alkaloids was car-
ried out according to the method of Tram et 
al. (2002). The residue from the aqueous 
extract above, was extracted with methanol 
and subjected to gas chromatographic 
analysis. Three grams of the crude aqueous 
extract was extracted with 25 mL of metha-
nol for 6 h at room temperature, before fil-
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tration. The filtrate was concentrated in a 
rotary evaporator, before “drying off” water 
using anhydrous sodium sulphate, prior to 
gas chromatography analysis. Gas chroma-
tographic analyses was carried out on an 
HP 6890 (Hewlett Packard, Wilmington, 
DE, USA), GC apparatus, fitted with a 
flame ionization detector (FID), and pow-
ered with HP Chemstation Rev. A 09.01 
[1206] software, to quantify and identify 
compounds. The column was a capillary 
DB-5MS (30 m × 0.25 mm × 0.25 µm film 
thickness). The inlet and detection tempera-
tures were 250 and 320 °C. Split injection 
was adopted with a split ratio of 20:1. Ni-
trogen was used as the carrier gas. The hy-
drogen and compressed air pressures were 
28 psi and 38 psi. The oven was pro-
grammed as follows: initial temperature at 
60 °C for 5 min; first ramping at 10 °C/min 
for 20 min, followed by a second ramping 
at 15 °C/min for 4 min. The chromatogram 
of the extract is shown in Figure 2. 
 
Experimental design for the hepatoprotec-
tive study 
Wistar albino rats (180-200 g) were col-
lected from the animal house of the De-
partment of Physiology, University of Ni-
geria, Enugu Campus. Studies were con-
ducted in compliance with applicable laws 
and regulations for handling experimental 
animals. The rats were weighed and sorted 
into eight groups (Table 1) of five animals 
each, so that their average weights were ap-
proximately equal. The animals were 
housed in plastic cages at the animal house 
of the Department of Biochemistry, Univer-
sity of Port Harcourt. After a one-week ac-
climatization period on guinea growers 
mash (Port Harcourt Flour Mills, Port Har-
court, Nigeria), the treatment commenced. 
The extract was administered orally on 
daily basis for eight days. The dosage of 
administration of the extract was adapted, 
with modification, from Ikewuchi and Ike-
wuchi (2010) and Ikewuchi (2010). The 
carbon tetrachloride was prepared 1:5 (v:v) 
in olive oil, and administered subcutane-
ously at 1 mL/kg body weight of carbon 
tetrachloride, on days 4 and 8. The dosage 
and method of administration of carbon tet-
rachloride was adapted from Obi and Uneh 
(2003), with modification. Twenty four 
hours after the last administration of carbon 
tetrachloride, the rats were weighed and 
anaesthetized by exposure to chloroform. 
While under anesthesia, they were 
painlessly sacrificed and blood was col-
lected from each rat into heparin sample 
bottles, after which the livers were collected 
and preserved in 10 % formalin, for histo-
chemical analysis. The heparin anti-co-
agulated blood samples were centrifuged at 
1000 g for 10 min, after which their plasma 
were collected and stored for subsequent 
analysis. 
 
 
Figure 2: Gas chromatogram of the alkaloid composition of an aqueous extract of Acalypha wilkesi-
ana leaves 
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Table 1: Experimental design for the hepatoprotective screening 
S/N ID Treatment 
1 Normal Olive oil (1 mL/kg) and normal saline and Water 
2 Test control Carbon tetrachloride (1 mL/kg) and water 
3 Treatment control I (AWC1) Olive oil (1 mL/kg) and extract (100 mg/kg) 
4 Treatment control II (AWC2) Olive oil (1 mL/kg) and extract (200 mg/kg) 
5 Treatment control III (AWC3) Olive oil (1 mL/kg) and extract (300 mg/kg) 
6 Treatment I (AW1) Carbon tetrachloride (1 mL/kg) and extract (100 mg/kg) 
7 Treatment II (AW2)  Carbon tetrachloride (1 mL/kg) and extract (200 mg/kg) 
8 Treatment III (AW3) Carbon tetrachloride (1 mL/kg) and extract (300 mg/kg) 
 
Determination of plasma hepatospecific 
markers 
The plasma activities of alanine and as-
partate transaminases, and alkaline phos-
phatase were determined using Randox test 
kits (Randox Laboratories Ltd., Crumlin, 
England, UK). The activities of alanine and 
aspartate transaminases were respectively 
measured by monitoring at 546 nm the con-
centrations of pyruvate and oxaloacetate 
hydrazones formed with 2,4-dinitrophenyl-
hydrazine. The activity of alkaline phos-
phatase was determined by monitoring the 
degradation of p-nitrophenylphosphate to p-
nitrophenol, at 405 nm.  
Plasma total bilirubin and protein con-
centrations were determined using Randox 
test kits (Randox Laboratories Ltd., Crum-
lin, England, UK). The wavelength for the 
determination of total bilirubin was 578 nm, 
while that of total protein was 560 nm. 
 
Determination of percentage protection  
(% protection) 
The percentage protection provided by 
the extract against carbon tetrachloride in-
duced liver damage was calculated using 
the following formula adapted from Al-
Qarawi et al. (2004). 
 
 
Histopathological study on the liver 
The histopathology study on the liver 
samples was carried out by Professor S.O. 
Nwosu, from the Department of Anatomical 
Pathology, University of Port Harcourt 
Teaching Hospital. Small pieces of liver 
tissues were collected in 10 % formalin for 
proper fixation. These tissues were proc-
essed and embedded in paraffin wax. Sec-
tions of 5-6 µm in thickness were cut, 
mounted on slide and stained with hema-
toxylin and eosin. The sections were then 
examined via light microscopy (Opticphot-
2; Nikon, Tokyo, Japan) at x100 magnifica-
tion. 
 
Statistical analysis of data 
All values are quoted as the mean ± 
s.e.m. (standard error in the mean). The val-
ues of the various parameters were analyzed 
for statistical significant differences be-
tween the groups, using the Student’s t-test, 
with the help of SPSS Statistics 17.0 pack-
age (SPSS Inc., Chicago Ill). P<0.05 was 
assumed to be significant. Graphs were 
drawn using Microsoft Office Excel, 2010 
software. 
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RESULTS AND DISCUSSION 
Table 2 shows the alkaloid composition 
of an aqueous extract of the leaves of Aca-
lypha wilkesiana. Thirty nine known alka-
loids were detected. The main constituents 
were 1.974 % echitamine, 26.226 % voacangine, 
0.599 % echitamidine, 69.027 % akuamidine, 
0.521 % lupanine, 0.278 % augustamine. 
The effect of an aqueous extract of the 
leaves of Acalypha wilkesiana on the 
plasma hepatospecific markers of normal 
and carbon tetrachloride treated rats is 
given in Table 3. Compared to test control, 
the treatment produced significantly lower 
(P<0.05) plasma alkaline phosphatase, 
alanine transaminase and aspartate transa-
minase activities. The plasma total bilirubin 
and total bilirubin of the test groups were 
lower though not significantly, than that of 
the test control. 
 
Table 2: Alkaloid composition of the aqueous extract of the leaves of Acalypha wilkesiana 
Compounds Retention time (min) Composition (x10-4 mg/kg)
Choline  7.060 23.34
Trigonelline 7.530 0.69
Angustifoline  7.938 587.47
Sparteine 8.927 44.78
Ellipcine  9.745 95.73
Lupanine 11.063 1422.77
13-α-Hydrorhombifoline 11.358 77.31
9-Octadecenamide 12.828 38.75
Dihydro-oxo-demethoxyhaemanthamine 14.156 179.31
Augustamine 14.924 759.94
Oxoassoanine 15.401 107.60
Cinchonidine 16.251 195.75
Cinchonine 16.374 117.95
Crinane-3α-ol 16.459 245.13
Buphanidrine 16.674 125.33
Indicine-N-oxide 17.551 97.41
Powelline 18.593 121.73
Undulatine 18.843 90.20
Ambelline 19.690 38.81
6-Hydroxybuphanidrine 20.468 164.84
Acronycine 21.102 113.47
Monocrotaline 21.329 151.05
6-Hydroxypowelline 21.822 210.00
Nitidine 22.362 101.43
Crinamidine 23.968 590.02
1β,2β-Epoxyambelline 24.726 56.04
6-Hydroxyundulatine 24.792 69.00
Epoxy-3,7-dimethoxycrinane-11-one 25.483 21.46
Akuamidine 26.841 188641.00
Echitamidine 26.953 1638.09
Voacangine 27.065 71672.60
Mitraphylin 27.650 0.05
Camptothecin 28.194 44.95
Echitamine 28.640 5393.51
Colchicine 28.930 26.58
Emetine 29.569 10.37
Tetrandrine 29.677 5.36
Thalicarpin 30.155 5.90
Paclitaxel 32.108 1.46
Total  - 273287.00
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Table 3: Effect of an aqueous extract of the leaves of Acalypha wilkesiana on the plasma hepato-
specific markers of normal and carbon tetrachloride treated rats 
Liver Function Indicator Treatment 
group Alkaline phos-
phatase activity 
(U/L) 
Aspartate 
transaminase 
activity (U/L) 
Alanine 
transaminase 
activity (U/L) 
Total bilirubin 
content 
(µmol/L) 
Total protein 
content (mg/dL)
Normal 327.52±89.49a,d 17.85±0.36a,d 23.17±1.97a 7.52±0.47a 58.31±3.06a,c 
Test control 1217.16±118.33c 49.88±1.67c 122.72±1.02c 9.10±1.25a 61.91±3.57a,b,c 
AWC1 260.13±43.22d,f 20.85±3.32d,f 20.89±3.38a 2.41±0.17c 55.32±1.74c,d 
AWC2 540.04±90.35a,b,d,f 20.74±2.50d,f 20.57±1.58a 3.24±0.19c 59.55±2.91a,c 
AWC3 523.85±137.31b,f 18.66±1.05d,f 22.53±4.83a 2.54±0.19c 48.90±1.93b,d 
AW1 476.93±106.63a,b,d,f 31.44±2.57b 62.52±10.08b 8.46±0.67a,b 61.38±5.90a,b,c 
AW2 394.68±82.26a,b,d,f 43.58±2.18c 119.51±1.09c 8.18±0.54a,b 60.67±2.11a 
AW3 409.86±34.48a,b 40.23±3.59b,c 78.17±10.31b 8.94±0.77a,b 56.31±2.70a,b,c 
Values are mean ± s.e.m., n=5, per group 
a,b,c Values in the same column with different superscripts are significantly different at P<0.05.  
 
 
The hepatoprotective activity of an 
aqueous extract of Acalypha wilkesiana 
leaves on carbon tetrachloride-induced 
hepatotoxicity in Wistar rats is shown in 
Figure 3. The protection against carbon tet-
rachloride damage seemed to be concentra-
tion dependent; with the 100 and 300 mg/kg 
doses being more effective. The treatment 
dose dependently significantly provided 
protection of about 83.21-92.45 % in alka-
line phosphatase, 19.65-57.56 % in aspar-
tate transaminase and 3.23-60.47 % alanine 
transaminase activities. The frequency dis-
tribution of the effect of an aqueous extract 
of the leaves of Acalypha wilkesiana on the 
liver histology of normal and carbon tetra-
chloride treated rats is shown in Figure 4; 
while sections of the liver samples are 
shown in Figure 5. 
 
Figure 3: Hepatoprotective activity of an aqueous extract of the leaves of Acalypha wilkesiana on  
carbon tetrachloride-induced hepatotoxicity in Wistar rats 
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Figure 4: The frequency distribution of the effects of an aqueous extract of the leaves of Acalypha 
wilkesiana on the liver histology of normal and carbon tetrachloride treated rats. A = normal, B = fatty 
change, C = focal areas of fatty change, D = enlarged hepatocyte with granular cytoplasm 
 
 
 
 
Figure 5: Sections (x20) of the liver samples showing the effect of an aqueous extract of the leaves of 
Acalypha wilkesiana on the liver histology of normal and carbon tetrachloride treated rats. A: Section 
of the liver of rats administered olive oil (1 mL/kg) and treated with water, showing normal cells. B: 
Section of the liver tissue of rats administered carbon tetrachloride (1 mL/kg) and treated with water, 
showing fatty change. C: Section of the liver of rats administered olive oil (1 mL/kg) and treated with 
100 mg/kg extract, showing normal cells. D: Section of the liver of rats administered olive oil (1 mL/kg) 
and treated with 200 mg/kg extract, showing normal cells. E: Section of the liver of rats administered 
olive oil (1 mL/kg) and treated with 300 mg/kg extract, showing normal cells. F: Section of the liver of 
rats administered carbon tetrachloride (1 mL/kg) and treated with 100 mg/kg extract, with very few 
cells showing fatty change. G: Section of the liver of rats administered carbon tetrachloride (1 mL/kg) 
and treated with 200 mg/kg extract, showing normal cells. H: Section of the liver of rats administered 
carbon tetrachloride (1 mL/kg) and treated with 300 mg/kg extract, showing enlarged hepatocytes with 
granular cytoplasm. 
 
 
Liver cirrhosis induced by carbon tetra-
chloride is perhaps the best-studied model 
of liver cirrhosis (Cornelius, 1993). The 
prevention of carbon tetrachloride-induced 
elevation of plasma aspartate and alanine 
transaminases and alkaline phosphatase ac-
tivities, and plasma bilirubin level, in ani-
mals pretreated with the aqueous extract of 
the leaves of Acalypha wilkesiana shows its 
ability to protect normal functional status of 
the poisoned liver, in addition to protecting 
against subsequent carbon tetrachloride 
hepatotoxicity. The mechanism by which 
the extract produces its hepatoprotective 
activity is not certain. However, it is possi-
ble that β-sitosterol, a constituent of the ex-
tract of the leaves of Acalypha wilkesiana 
(Ikewuchi et al., 2011a), is at least partly 
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responsible for the protective activity 
against carbon tetrachloride hepatotoxicity. 
Earlier, Lin and Tome (1988) had reported 
that β-sitosterol was the anti-hepatotoxic 
principle in Sambucus formosana. 
Carbon tetrachloride toxicity and its ini-
tiation of lipid peroxidation can be dimin-
ished by reducing the metabolic activation 
of carbon tetrachloride to trichloromethyl 
free radical by cytochrome P450 (Middle-
ton et al., 2000). Therefore, any hepatopro-
tective agent should be able to inhibit the 
aromatase activity of cytochrome P450, and 
by so doing, favour liver regeneration. Fla-
vonoids inhibit cytochrome P450 aromatase 
(Kowalska et al., 1990; Middleton et al., 
2000), and may also inhibit lipid peroxida-
tion by exerting a membrane-stabilizing 
action (Middleton et al., 2000). So, it can be 
suggested that flavonoids in A. wilkesiana 
leaves (Ikewuchi et al., 2010, 2011a), could 
be responsible for their hepatoprotective 
ability.  
Earlier, Ikewuchi et al. (2010, 2011a) 
had reported that the leaves and aqueous 
extract of the leaves of A. wilkesiana were 
very rich in tannins and tannic acid. This 
may also be responsible for the hepatopro-
tective activity observed in this study. The 
hepatoprotective activity of tannic acid is 
well documented (Mittal et al., 2010; Pitha-
yanukul et al., 2009). 
Vitamin C, one of the major constitu-
ents of the leaves of A. wilkesiana (Ike-
wuchi and Ikewuchi, 2009) may also have 
contributed to, or be responsible for the 
hepatoprotection observed here. Studies 
have shown that hepatic microsomal drug 
metabolism is improved with vitamin C 
supplementation, probably due its augmen-
tation of cytochrome P450 (Sato and Zan-
noni, 1976; Rikans et al., 1978; Burtis and 
Ashwood, 2001). 
 
CONCLUSION 
This study clearly demonstrates that ex-
tracts of the leaves of Acalypha wilkesiana 
are effective agents in the treatment and 
prevention of carbon tetrachloride-induced 
hepatic cytotoxicity. The data suggest that 
the daily oral consumption of an aqueous 
extract of the leaves of Acalypha wilkesiana 
was prophylactic to carbon tetrachloride 
poisoning. 
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